COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,228 Articles (22,733 medRxiv, 8,495 bioRxiv)

Most recent first Previous |  Page 552: Articles 5511-5520  | Next

Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Ito, J., Suzuki, R., Uriu, K., Itakura, Y., Zahradnik, J., Deguchi, S., Wang, L., Lytras, S., Tamura, T., Kida, I., Nasser, H., Shofa, M., Begum, M. M., Tsuda, M., Oda, Y., Fujita, S., Yoshimatsu, K., Ito, H., Nao, N., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Yamamoto, Y., Nagamoto, T., Schreiber, G., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Saito, A., Matsuno, K., Takayama, K., Tanaka, S., Fukuhara, T., Ikeda, T., Sato, K.
10.1101/2022.12.05.519085 — Posted: 2022-12-05
Enhanced Protection from SARS-CoV-2 Variants by MVA-Based Vaccines Expressing Matched or Mismatched S Proteins Administered Intranasally to hACE2 Mice
Cotter, C. A., Americo, J. L., Earl, P. L., Moss, B.
10.1101/2022.12.03.518963 — Posted: 2022-12-05
Deep mutational scanning to predict antibody escape in SARS-CoV-2 Omicron subvariants
Alcantara, M. C., Higuchi, Y., Kirita, Y., Matoba, S., Hoshino, A.
10.1101/2022.12.02.518937 — Posted: 2022-12-05
Bioinformatics techniques for efficient structure prediction of SARS-CoV-2 protein ORF7a via structure prediction approaches
Kazmi, A., Kazim, M., Aslam, F., Kazmi, S. M.-u.-H., Wahab, A., Mikhlef, R. M., Khizar, C., Kazmi, A., Wazir, N. U., Mainali, R. P.
10.1101/2022.12.03.518956 — Posted: 2022-12-05
Convergent evolution in SARS-CoV-2 Spike creates a variant soup that causes new COVID-19 waves.
Focosi, D., Quiroga, R., McConnell, S., Johnson, M. C., Casadevall, A.
10.1101/2022.12.05.518843 — Posted: 2022-12-05
New insights into the structure of Comirnaty Covid-19 vaccine: A theory on soft nanoparticles with mRNA-lipid supercoils stabilized by hydrogen bonds
Szebeni, J., Kiss, B., Bozo, T., Turjeman, K., Levi-Kalisman, Y., Barenholz, Y., Kellermayer, M.
10.1101/2022.12.02.518611 — Posted: 2022-12-05
A Generalized Multinomial Probabilistic Model for SARS-CoV-2 Infection Prediction and Public Health Intervention Assessment in an Indoor Environment
Li, V. O., Lam, J. C., Sun, Y., Han, Y., Chan, K., Wang, S.-s., Crowcroft, J., Downey, J., Zhang, Q.
10.1101/2022.12.02.22282697 — Posted: 2022-12-05
Bayesian Spatio-temporal prediction and counterfactual generation: an application in non-pharmaceutical interventions in Covid-19.
Lawson, A. B., Rotejanaprasert, C.
10.1101/2022.11.30.22282938 — Posted: 2022-12-05
Optimizing COVID-19 testing strategies on college campuses: evaluation of the health and economic costs
Johnson, K. E., Pasco, R., Woody, S., Lachmann, M., Johnson-Leon, M., Bhavnani, D., Klima, J., Paltiel, A. D., Fox, S., Meyers, L. A.
10.1101/2022.12.04.22283074 — Posted: 2022-12-05
Risk of Type 1 Diabetes in Children is Not Increased after SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark
Noorzae, R., Junker, T. G., Hviid, A. P., Wohlfahrt, J., Olsen, S. F.
10.1101/2022.12.05.22283089 — Posted: 2022-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).